How much did Epitome Therapeutics raise?

Epitome Therapeutics raised €4M at Pre-Seed, announced 30 June 2026.

Who founded Epitome Therapeutics?

Guido Gualdoni is CEO & Co-founder of Epitome Therapeutics.

What does Epitome Therapeutics do?

Epitome Therapeutics operates in HealthTech and is based in Austria.

FundedStartupsDaily / HealthTech / Epitome Therapeutics

Epitome Therapeutics raises €4M

Epitome Therapeutics announced a Pre-Seed round of €4M on 30 June 2026. The company operates in HealthTech and is based in Austria. It was founded by Guido Gualdoni, CEO & Co-founder.

Raised

€4M

Stage

Pre-Seed

Industry

HealthTech

Country

Austria

Founder

Guido Gualdoni

CEO & Co-founder, Epitome Therapeutics

LinkedIn profile epitome-tx.com

Outreach angles

-Guido Gualdoni is a physician-scientist who co-founded Epitome Therapeutics in 2025 as an EMBL spin-off.
-He built the company with CSO Dr. Jamie Hackett around research published in Nature Genetics on precision epigenome editing.
-The €4M pre-seed, combining a €2M equity round with €2M in grants, advances programmes for rare and metabolic diseases and grows the team.